Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Collegium Pharmaceutical stock (COLL)

Buy Collegium Pharmaceutical stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Collegium Pharmaceutical is a drug manufacturers - specialty & generic business based in the US. Collegium Pharmaceutical shares (COLL) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $39.34 – an increase of 7.37% over the previous week. Collegium Pharmaceutical employs 197 staff and has a trailing 12-month revenue of around $576.7 million.

Our top picks for where to buy Collegium Pharmaceutical stock

Best for mobile experience

Go to site
  • Earn 4.5% interest on uninvested cash with Gold
  • Get up to $50,000 in instant deposits with Gold
  • Easy, user-friendly trading
  • Unlimited bonus amounts Oct 16-27

Top pick for advanced traders

Go to site
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for transfer bonus

Go to site
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • Complimentary access to a financial planner and automated investing

How to buy Collegium Pharmaceutical stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – COLL. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Collegium Pharmaceutical stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 5 of 5
Name Product USFST Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Robinhood
Finder Score: 4.4 / 5: ★★★★★
Bonus
Robinhood
★★★★★
Stocks, Options, ETFs, Cryptocurrency
$0
$0
4.5%
Earn 1–3% on transfers from Oct 16–27
Trade stocks, options, ETFs and crypto without commissions and on a user-friendly platform. Plus, a 1% IRA match and no options contract fees.
Tastytrade
Finder Score: 4.4 / 5: ★★★★★
Tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
★★★★★
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $1,000 in stock
Zero-commission stocks, ETFs and options, with no options per-contract fees. Plus, a no-advisory-fee robo-advisor and complimentary access to financial planners.
OPTO
Finder Score: 3.1 / 5: ★★★★★
OPTO
★★★★★
Stocks, ETFs
$0
$0
N/A
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
eToro
Finder Score: 4 / 5: ★★★★★
EXCLUSIVE
eToro
★★★★★
Stocks, Options, ETFs, Cryptocurrency
$0
$0
4.9%
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
No commission stock, ETF and options trades, with 4.9% interest on your options account balance and no options contract fees.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Collegium Pharmaceutical stock price (NASDAQ: COLL)

Use our graph to track the performance of COLL stocks over time.

Collegium Pharmaceutical shares at a glance

Information last updated 2024-10-16.
Latest market close$39.34
52-week range$20.95 - $42.29
50-day moving average $37.34
200-day moving average $35.29
Wall St. target price$43.25
PE ratio 14.485
Dividend yield N/A
Earnings per share (TTM) $2.66

Is it a good time to buy Collegium Pharmaceutical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Collegium Pharmaceutical price performance over time

Historical closes compared with the close of $38 from 2024-10-14

1 week (2024-10-10) 3.71%
1 month (2024-09-17) 1.66%
3 months (2024-07-17) 18.97%
6 months (2024-04-17) 7.19%
1 year (2023-10-17) 73.04%
2 years (2022-10-17) 108.22%
3 years (2021-10-15) 81.12%
5 years (2019-10-17) 214.57%

Is Collegium Pharmaceutical stock undervalued or overvalued?

Valuing Collegium Pharmaceutical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Collegium Pharmaceutical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Collegium Pharmaceutical's P/E ratio

Collegium Pharmaceutical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 14x. In other words, Collegium Pharmaceutical shares trade at around 14x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Collegium Pharmaceutical's EBITDA

Collegium Pharmaceutical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $347.4 million.

The EBITDA is a measure of a Collegium Pharmaceutical's overall financial performance and is widely used to measure a its profitability.

Collegium Pharmaceutical financials

Revenue TTM $576.7 million
Operating margin TTM 32.68%
Gross profit TTM $345.7 million
Return on assets TTM 11.24%
Return on equity TTM 47.87%
Profit margin 17.32%
Book value $6.70
Market Capitalization $1.2 billion

TTM: trailing 12 months

Collegium Pharmaceutical share dividends

We're not expecting Collegium Pharmaceutical to pay a dividend over the next 12 months.

Collegium Pharmaceutical share price volatility

Over the last 12 months, Collegium Pharmaceutical's shares have ranged in value from as little as $20.95 up to $42.2873. A popular way to gauge a stock's volatility is its "beta".

COLL.US volatility(beta: 0.93)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Collegium Pharmaceutical's is 0.932. This would suggest that Collegium Pharmaceutical's shares are less volatile than average (for this exchange).

Collegium Pharmaceutical overview

Collegium Pharmaceutical, Inc. , a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, and oral formulation of oxycodone for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; Belbuca, a buccal film that contains buprenorphine; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc.

Frequently asked questions

null
What percentage of Collegium Pharmaceutical is owned by insiders or institutions?
Currently 1.317% of Collegium Pharmaceutical shares are held by insiders and 125.895% by institutions.
How many people work for Collegium Pharmaceutical?
Latest data suggests 197 work at Collegium Pharmaceutical.
When does the fiscal year end for Collegium Pharmaceutical?
Collegium Pharmaceutical's fiscal year ends in December.
Where is Collegium Pharmaceutical based?
Collegium Pharmaceutical's address is: 100 Technology Center Drive, Stoughton, MA, United States, 02072
What is Collegium Pharmaceutical's ISIN number?
Collegium Pharmaceutical's international securities identification number is: US19459J1043
What is Collegium Pharmaceutical's CUSIP number?
Collegium Pharmaceutical's Committee on Uniform Securities Identification Procedures number is: 19459J104

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site